Neuroone Medical Technologies (NMTC) Operating Expenses (2010 - 2026)

Neuroone Medical Technologies has disclosed Operating Expenses across 17 years of filings, most recently posting $3.4 million for Q1 2026.

• Quarterly Operating Expenses fell 1.84% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (down 2.65% YoY) and the FY2025 annual result came in at $12.4 million, down 4.62% from the prior year.
• Operating Expenses climbed to $3.4 million in Q1 2026, from $3.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $3.8 million in Q2 2023 and bottomed at $2.8 million in Q2 2022.
• The 5-year median for Operating Expenses is $3.3 million (2025), against an average of $3.2 million.
• Year-over-year, Operating Expenses surged 36.26% in 2023 and dropped 18.06% in 2024.
• Neuroone Medical Technologies' Operating Expenses stood at $3.2 million in 2022, then climbed by 13.31% to $3.7 million in 2023, then dropped by 12.06% to $3.2 million in 2024, then climbed by 1.85% to $3.3 million in 2025, then rose by 3.43% to $3.4 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $3.4 million, $3.3 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.